Get advice for managing Multiple Sclerosis: Watch the video.

Ropinirole Pregnancy and Breastfeeding Warnings

Ropinirole is also known as: ReQuip Follow on Pack, ReQuip Starter Pack, Repreve, Requip, Requip Starter Kit, Requip XL

Ropinirole Pregnancy Warnings

Ropinirole has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of adverse effects on embryo-fetal development, including teratogenic effects. There are no controlled data in human pregnancy. Ropinirole is only recommended for use during pregnancy when benefit outweighs risk.

The administration of ropinirole to rats during organogenesis resulted in decreased fetal body weight at 60 mg/kg/day, increased fetal death at 90 mg/kg/day, and digital malformations at 150 mg/kg/day, respectively. (All doses were administered only on selected dates during the pregnancy.)

Ropinirole Breastfeeding Warnings

Animal studies have shown ropinirole and/or its metabolite(s) are excreted into breast milk.

Ropinirole inhibits prolactin secretion in humans and may inhibit lactation. There are no data on the excretion of ropinirole into human milk. Because many drugs are excreted into human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web2)